SAILIFEPharmaceuticals
Sai Life Sciences Ltd — PE Ratio & Valuation Analysis
₹972.00
-1.32%
Current P/E64.17xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E147.1x56.4% below avg
⚠️
102.0% Premium to Industry
SAILIFE P/E 64.17x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹8.61 | ₹908 | 105.5x |
| 2024 | ₹3.98 | ₹751 | 188.7x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Sai Life Sciences Ltd Valuation
Sai Life Sciences Ltd (SAILIFE) currently trades at 64.17x earnings. The Pharmaceuticals sector average PE is 31.77x. SAILIFE commands a premium, reflecting high growth expectations. Historically, SAILIFE has traded at an average PE of 147.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
11.05%
Dividend Yield
0.00%
More on Sai Life Sciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.